期刊文献+

糖皮质激素与他克莫司软膏治疗成人特应性皮炎的不良反应对比分析 被引量:7

Comparative analysis of adverse drug reactions caused by Glucocorticoid and Tacrolimus Ointment in the treatment of atopic dermatitis
下载PDF
导出
摘要 目的:比较糖皮质激素与他克莫司软膏治疗成人特应性皮炎(AD)发生不良反应的情况,评价二者治疗成人AD的安全性。方法:将100例成人AD患者随机分为糖皮质激素组和他克莫司软膏组,每组50例,分别给予外用糖皮质激素及他克莫司软膏治疗,观察并比较两组治疗成人AD的疗效及不良反应发生情况。结果:他克莫司软膏组总有效率高于糖皮质激素组(94.0%对78.0%,P<0.05),药物相关不良反应的发生率明显低于糖皮质激素组(24.0%对40.0%,P<0.01),主要不良反应为局部瘙痒、刺痛,程度轻,多可自行缓解;糖皮质激素组不良反应多,程度重,主要是局部皮肤萎缩、类固醇性痤疮、多毛、激素性潮红、局部皮肤刺痛、烧灼感等,多需给予对症治疗。结论:他克莫司软膏治疗AD疗效好,不良反应少且轻,用药安全,值得临床推广使用。 Objective:To compare the adverse drug reactions(ADR) caused by Glucocorticoid(GC) and Tacrolimus Ointment in the treatment of atopic dermatitis(AD),and evaluate the safety of the two drugs in the treatment of AD in clinic.Methods:A total of 100 patients with adult AD were randomly divided into GC group and Tacrolimus Ointment group,with 50 patients in each group.Patients in the two groups were respectively given GC and Tacrolimus Ointment for external use,and the efficacy as well as the occurrence of ADR in the two groups were observed and compared.Results:The total effective rate of Tacrolimus Ointment group was significantly higher than that of the GC group(94.0% vs 78.0%,P0.05),the incidence of drug-related ADR was obviously lower than that of GC group(24.0% vs 40.0%,P0.01),and the main ADR were local skin pruritus and pricking pain,all the clinical manifestations of ADR were mild and could be relieved without special treatment.GC group had more and severe clinical manifestations of ADR than those of Tacrolimus Ointment group,the main ADR were local dermatrophia,steroid acne,crinosity,steroid-induced flush,local skin pricking pain,burning sensation and so on,and needed symptomatic treatment.Conclusion:Tacrolimus Ointment has a better efficacy in the treatment of AD,the ADR are less and mild,the medication is safe and is worthy of application in clinic.
出处 《中国医药导报》 CAS 2011年第6期104-105,108,共3页 China Medical Herald
关键词 特应性皮炎 成人 他克莫司软膏 不良反应 Atopic dermatitis Adults Tacrolimus Ointment Adverse drug reaction
  • 相关文献

参考文献11

二级参考文献39

  • 1刘玲玲,窦侠,闻卫兢,郑志忠,王宝玺,林麟,曾凡钦,顾军,朱学骏.他克莫司软膏治疗成人特应性皮炎疗效和安全性研究[J].中华皮肤科杂志,2005,38(7):406-409. 被引量:29
  • 2顾恒.糖皮质激素依赖性皮炎的诊断与治疗[J].中华皮肤科杂志,2007,40(1):5-6. 被引量:190
  • 3Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ. 2006, 332(7541 ): 584-588.
  • 4Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy, 2006, 61 (8): 969-987.
  • 5Lipozencic J, Wolf R. Atopic dermatitis: an update and review of the literature. Dermatol Clin, 2007, 25(4): 605-612.
  • 6Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol, 1994, 131(3): 383-396.
  • 7Reynolds NJ, Franklin V, Gray JC, et al. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomized controlled trial. Lancet, 2001,357 : 2012-2016.
  • 8Hoare C,Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess, 2000,4:1-191.
  • 9Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent corticostemid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ, 2002,324:768.
  • 10Berth-Jones J, Damstra RJ, Golsch S, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomized, double blind, parallel group study. BMJ, 2003, 326:1367.

共引文献205

同被引文献58

  • 1孙晓雨,崔子寅,张明亮,孙长江,佟春玉,冯新,顾敬敏,雷连成,韩文瑜.枸杞多糖和茯苓多糖对免疫抑制小鼠免疫增强及对肠道黏膜的免疫调节作用[J].中国兽医学报,2015,35(3):450-455. 被引量:57
  • 2颜艳,鞠梅,于建斌,毕志刚,陈昆,顾恒.复方氟米松软膏治疗湿疹皮炎类皮肤病临床疗效观察[J].中华皮肤科杂志,2006,39(2):116-117. 被引量:125
  • 3王豫巍,王永钧.白芍总苷在自身免疫性疾病中的药理研究与临床应用[J].浙江中医药大学学报,2007,31(2):240-241. 被引量:52
  • 4Baggiolini M. Chemokine and leukocyte traffic[J]. Nature, 1998,392(6 676) : 565 - 568.
  • 5Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4 - bearing Th2 cells toward antigen - presenting cells by the CC chemokine thymus and activation -regulated chemokine and macrophage- derived chemokine [J]. Int Immunol, 1999,11 ( 1 ) : 81 - 88.
  • 6Vestergaard C, Yoneyama H, Mural M, et al. Overproduction of Th2 CC chemokines TARC and MDC in the skin of the NC/Nga mouse correlates with exacerbation of atopic dermatitis skin[J]. J Invest Dermatol, 2000, 115 : 640 - 646.
  • 7Yu B, Koga T, Urabe K, ct al. Differential regulation of thymus - and acti- vation -regulated chemokine induced by IL- 4, IL- 13, TNF -alpha and IFN- gamma in human keratinocyte and fibroblast[J]. J Dermatol Sci, 2002,30( 1 ) : 29 - 36.
  • 8Kaplan AP. Chemokines, chemokine receptors and allergy [ J ]. Int Arch Al- lergy Immunol,2001,124(4) :423 - 31.
  • 9Kido M,Takeuchi S, Esaki H, et al. Scratching behavior does not necessar- ily correlate with epidermal nerve fiber sprouting or inflammatory cell infil- tration[J]. J Dermatol Sci ,2010,58 : 130 - 135.
  • 10Leung DYM. Atopic dermatitis: new insights and opportunities for thera- peutic intervention [ J ]. J Allergy Clin Immunol, 2000,105:860 - 876.

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部